Skip to main content

Table 1 Patient characteristics

From: Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes

 

p16-positive

n = 72 (%)

p16-negative

n = 590 (%)

p-value

Median Age (years, range)

58 (38–84)

62 (20–95)

0.252

 Age ≥ 65

24 (33)

242 (41)

ECOG

 0–1

67 (93)

532 (90)

0.528

 ≥ 2

5 (7)

58 (10)

Sex

 Male

53 (74)

441 (75)

0.886

 Female

19 (26)

149 (25)

Smoking

  Never

28 (40)

193 (35)

0.427

  Ever

42 (60)

361 (65)

  Mean pack-year (+/−SD)

23.9 (14.3)

26.3 (18.2)

0.418

 Missing

2

36

Site of primary tumor

 Oral cavity

12 (17)

245 (41)

< 0.001

 Oropharynx

38 (53)

99 (17)

 Larynx

13 (18)

131 (22)

 Hypopharynx

5 (7)

89 (15)

 Paranasal sinus

4 (6)

23 (4)

 Unknown primary

0

3 (1)

Site of primary tumor

 Oropharynx

38 (53)

99 (17)

< 0.001

 Non-oropharynx

34 (47)

491 (83)

Histology grade

 Well differentiated

7 (12)

194 (38)

< 0.001

 Moderately differentiated

34 (57)

226 (44)

 Poorly-differentiated

13 (22)

37 (7)

 Undifferentiated

6 (10)

59 (11)

 Non-specific type

12

74

Stage at Diagnosis (AJCC 7th)

 I

6 (8)

85 (15)

0.425

 II

8 (11)

52 (9)

 III

11 (15)

91 (15)

 IVa/b

45 (63)

325 (55)

 IVc

2 (3)

35 (6)

T-stage

 1–2

36 (50)

224 (38)

0.057

 3–4

36 (50)

360 (62)

 Tx

0

6

N-Stage

 0

21 (29)

261 (44)

0.049

 1

14 (19)

96 (16)

 2

33 (46)

188 (32)

 3

4 (6)

44 (8)

 Nx

0

1

Definitive treatment for locally advanced disease

 Surgery alone

23 (32)

306 (54)

< 0.001

 Surgery with adjuvant CRT

9 (14)

83 (15)

 Definitive CRT

39 (55)

179 (31)